← All briefings
📰

subtl daily briefing

Share𝕏inEmail
AllAICryptoSaaSFinanceStartups

Good morning, Hustle readers. This week's recap is a wild ride—spanning a startup that wants your dog's poop, a biotech growing human tissue in labs, and the rise of sorority rush coaches. Let's dig into the biggest stories from the business world's strangest corners.

In today's briefing

  • 1.Petwealth turns dog poop into health data
  • 2.Vivodyne replaces animal testing with lab-grown tissue
  • 3.Sorority rush coaches become a campus business
  • ⚡Quick hits on other news
Latest Developments
Other

💩Petwealth turns dog poop into at-home health data

The Rundown: Petwealth is a new startup that lets pet owners mail in dog stool samples for at-home diagnostic testing.

The details:

  • ●Pet owners collect and mail in stool samples instead of making a vet visit.
  • ●Testing aims to catch digestive issues, parasites, and other health problems early.
  • ●The service fits a growing trend of consumer-friendly pet health diagnostics.
  • ●It removes the stress of vet visits for dogs while giving owners actionable insights.
Why it matters: For founders, Petwealth is a reminder that niche, emotionally-driven markets can support real businesses. Pet owners spend heavily on their animals' health and are increasingly open to convenience-first diagnostics that bypass traditional clinics, creating room for startups to disrupt the pet care experience.

📰 Source: The Hustle

Share𝕏inEmail
Other

🧫Vivodyne replaces animal testing with lab-grown human tissue

The Rundown: Biotech startup Vivodyne is developing lab-grown human tissue to make drug testing more humane and relevant.

The details:

  • ●Vivodyne uses lab-grown human tissue models instead of animals for drug development.
  • ●The approach could reduce reliance on animal testing while improving accuracy for human responses.
  • ●It's part of a broader biotech shift toward organ-on-a-chip and 3D tissue engineering.
  • ●The tech has potential to speed up preclinical testing and lower drug development costs.
Why it matters: For investors and founders, this hits two big themes: regulatory pressure and scientific innovation. If lab-grown tissue can outperform animal models, it opens a massive B2B market in pharma R&D and could fundamentally reshape how drugs come to market.

📰 Source: The Hustle

Share𝕏inEmail
Other

🎓Sorority rush coaches become a campus business

The Rundown: A new wave of coaches is helping students navigate sorority rush to secure spots in top-tier houses.

The details:

  • ●Services include application prep, outfit planning, and strategy for recruitment events.
  • ●Demand is rising among students and parents who want an edge in competitive Greek life.
  • ●Coaches are often former sorority members or consultants with insider knowledge.
  • ●The trend mirrors the broader 'experience economy' of paid advice for major life milestones.
Why it matters: This is a classic arbitrage play: when an opaque process creates anxiety, a middleman appears. Startups can monetize scarcity and social pressure, but they also face questions about fairness and exclusivity—a delicate balance for any founder entering the campus services space.

📰 Source: The Hustle

Share𝕏inEmail
⚡

Everything else in the news today

The Hustle's recap also highlighted confusing tech ads on subways that left commuters scratching their heads.→
Biotech startups working on animal-free testing are gaining attention from investors and regulators alike.→
Pet health startups are expanding beyond diagnostics into personalized nutrition and DNA testing.→
Sorority rush coaching reflects a broader wave of paid 'life strategy' services aimed at Gen Z.→
The newsletter's weekly roundup included a list of interesting longreads and web finds for curious readers.→
📰Briefing📈Intelligence📚Library